Goodwill and Intangible Assets - Goodwill (Details) - USD ($) $ in Millions |
12 Months Ended | |
|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
|
| Goodwill and Intangible Assets | ||
| Goodwill | $ 23,231 | $ 23,744 |
| Increase (decrease) in goodwill due to foreign currency translation adjustments | (532) | 550 |
| Amount of reductions of goodwill relating to impairments | 0 | $ 0 |
| Established Pharmaceutical Products | ||
| Goodwill and Intangible Assets | ||
| Goodwill | 2,800 | |
| Nutritional Products | ||
| Goodwill and Intangible Assets | ||
| Goodwill | 286 | |
| Diagnostic Products | ||
| Goodwill and Intangible Assets | ||
| Goodwill | 3,700 | |
| Medical Devices | ||
| Goodwill and Intangible Assets | ||
| Goodwill | $ 16,400 | |
| X | ||||||||||
- Definition Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|